Literature DB >> 26198592

Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.

Lénaig Mescam-Mancini1, Yves Allenbach2, Baptiste Hervier2, Hervé Devilliers3, Kuberaka Mariampillay4, Odile Dubourg5, Thierry Maisonobe6, Romain Gherardi5, Paulette Mezin1, Corinna Preusse7, Werner Stenzel7, Olivier Benveniste8.   

Abstract

Idiopathic inflammatory myopathies can be classified as polymyositis, dermatomyositis, immune-mediated necrotizing myopathy, sporadic inclusion body myositis or non-specific myositis. Anti-Jo-1 antibody-positive patients are assigned to either polymyositis or dermatomyositis suggesting overlapping pathological features. We aimed to determine if anti-Jo-1 antibody-positive myopathy has a specific morphological phenotype. In a series of 53 muscle biopsies of anti-Jo-1 antibody-positive patients, relevant descriptive criteria defining a characteristic morphological pattern were identified. They were tested in a second series of anti-Jo-1 antibody-positive patients and compared to 63 biopsies from patients suffering from other idiopathic inflammatory myopathies. In anti-Jo-1 antibody-positive patients, necrotic fibres, which strongly clustered in perifascicular regions, were frequently observed. Sarcolemmal complement deposition was detected specifically in perifascicular areas. Inflammation was mainly located in the perimysium and around vessels in 90.6%. Perimysial fragmentation was observed in 90% of cases. Major histocompatibility complex class I staining was diffusely positive, with a perifascicular reinforcement. Multivariate analysis showed that criteria defining perifascicular pathology: perifascicular necrosis, atrophy, and perimysial fragmentation allow the distinction of anti-Jo-1 antibody-positive patients, among patients suffering from other idiopathic inflammatory myopathies. Anti-Jo-1 antibody-positive patients displayed perifascicular necrosis, whereas dermatomyositis patients exhibited perifascicular atrophy.
© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  anti-synthetase; dermatomyositis; idiopathic inflammatory myopathies; necrotizing myopathies; polymyositis

Mesh:

Substances:

Year:  2015        PMID: 26198592     DOI: 10.1093/brain/awv192

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  35 in total

Review 1.  Classification of myositis.

Authors:  Ingrid E Lundberg; Marianne de Visser; Victoria P Werth
Journal:  Nat Rev Rheumatol       Date:  2018-04-12       Impact factor: 20.543

Review 2.  Myositis in 2016: New tools for diagnosis and therapy.

Authors:  Ingrid E Lundberg
Journal:  Nat Rev Rheumatol       Date:  2017-01-25       Impact factor: 20.543

Review 3.  Autoimmune Myopathies.

Authors:  Andrew L Mammen
Journal:  Continuum (Minneap Minn)       Date:  2016-12

4.  Anti-aminoacyl-tRNA synthetase-related myositis and dermatomyositis: clues for differential diagnosis on muscle biopsy.

Authors:  Bruna Cerbelli; Annalinda Pisano; Serena Colafrancesco; Maria Gemma Pignataro; Marco Biffoni; Silvia Berni; Antonia De Luca; Valeria Riccieri; Roberta Priori; Guido Valesini; Giulia d'Amati; Carla Giordano
Journal:  Virchows Arch       Date:  2017-11-16       Impact factor: 4.064

Review 5.  Immune-mediated necrotizing myopathy.

Authors:  C Bergua; H Chiavelli; J P Simon; O Boyer; F Jouen; W Stenzel; J Martinet
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

Review 6.  Autoantibodies in myositis.

Authors:  Neil J McHugh; Sarah L Tansley
Journal:  Nat Rev Rheumatol       Date:  2018-04-20       Impact factor: 20.543

7.  Interstitial lung disease and inflammatory myopathy in antisynthetase syndrome with PL-12 antibody.

Authors:  Ameen Jubber; Mudita Tripathi; James Taylor
Journal:  BMJ Case Rep       Date:  2018-10-14

8.  Skeletal Muscle Involvement in Antisynthetase Syndrome.

Authors:  Eri Noguchi; Akinori Uruha; Shigeaki Suzuki; Kohei Hamanaka; Yuko Ohnuki; Jun Tsugawa; Yurika Watanabe; Jin Nakahara; Takashi Shiina; Norihiro Suzuki; Ichizo Nishino
Journal:  JAMA Neurol       Date:  2017-08-01       Impact factor: 18.302

9.  The association between myositis-specific autoantibodies and muscle pathologies in idiopathic inflammatory myopathies.

Authors:  Qiu Xu; Qiu-Xiang Li; Fang-Fang Bi; Hui-Qian Duan; Yue-Bei Luo; Huan Yang
Journal:  Clin Rheumatol       Date:  2020-07-15       Impact factor: 2.980

Review 10.  Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.

Authors:  Paige W Wolstencroft; David F Fiorentino
Journal:  Curr Rheumatol Rep       Date:  2018-04-10       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.